Springer Science and Business Media LLC
Cure8 research brief
Why This Matters
A multimodal, simpler activity score could improve practical disease monitoring when full ileocolonoscopy isn’t possible and help standardize treat-to-target practice across centers.
Who Should Pay Attention
Clinicians managing Crohn’s disease, researchers working on disease activity measures or imaging, and centers that perform IBD monitoring where incomplete colonoscopies are common.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
Researchers developed MAS-CD from four scored parameters (ulcer size, ulcerated surface, affected surface, stenosis severity) and incorporated CT enterography, optional MRE, or intestinal ultrasound when ileocolonoscopy was incomplete.
In multicenter testing the score showed substantial interobserver agreement and correlated strongly with SES-CD and modestly with CRP, fecal calprotectin, albumin, and clinical indices.
In the validation cohort MAS-CD differentiated remission from active disease and small-bowel versus colonic-predominant disease, and the authors report better prediction of treatment response than SES-CD in their sample.
How this was done This is a multicenter development and prospective validation study with an initial inter-rater reproducibility cohort (n=157) and an independent validation cohort (n=91). Correlations with endoscopic scores, clinical indices, and biomarkers were evaluated; imaging modalities were used to fill gaps from incomplete colonoscopies.
Keep In Mind
This record is a posted research abstract (Research Square) and the structured content depth is abstract; findings have not completed full peer-reviewed publication here. Reported diagnostic performance and predictive claims are from the authors’ validation cohorts and should be confirmed in wider, independent studies before changing practice.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationSpringer Science and Business Media LLC
AuthorsMing Xu, Xiaoyue Yang, Li Xie +4 more
Study typePosted Content
Indexed viaCrossref
Source typeResearch paper
PublishedSep 30, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
People with IBD who have no or few symptoms but still have moderate–severe inflammation on endoscopy face uncertainty about whether to switch therapies to aim for endoscopic remission.
Diagnostic accuracy of the international bowel ultrasound segmental activity score for assessing disease activity in Crohn’s disease
Standardized intestinal ultrasound scoring could help non-invasively monitor Crohn’s disease activity and reduce reliance on colonoscopy for some assessments. A high-sensitivity IUS score may be useful to rule out...
Intestinal ultrasound: a non-invasive alternative to monitor and predict biologic treatment persistence in patients with inflammatory bowel disease.
A non-invasive test (intestinal ultrasound) that predicts whether patients stay on biologic therapy could reduce the need for frequent endoscopy and help guide monitoring decisions.